CLINICAL_TRIALS
trial_result
· 2026-07-27
Clinical Trial Results: A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma [Phase 1, Phase 2]
Summary
A multicenter Phase 1/2 study evaluating recombinant vaccinia virus therapy for malignant melanoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jennerex Biotherapeutics | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-07-27